Coordinatore | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Organization address
address: CHARILAOU THERMI ROAD 6 KM contact info |
Nazionalità Coordinatore | Greece [EL] |
Totale costo | 5˙584˙782 € |
EC contributo | 3˙892˙540 € |
Programma | FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies |
Code Call | FP7-NMP-2011-SMALL-5 |
Funding Scheme | CP-FP |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-02-01 - 2015-01-31 |
# | ||||
---|---|---|---|---|
1 |
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Organization address
address: CHARILAOU THERMI ROAD 6 KM contact info |
EL (THERMI THESSALONIKI) | coordinator | 484˙379.40 |
2 |
TECHNISCHE UNIVERSITEIT DELFT
Organization address
address: Stevinweg 1 contact info |
NL (DELFT) | participant | 392˙850.00 |
3 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 374˙220.00 |
4 |
UNIVERSITY OF STRATHCLYDE
Organization address
address: Richmond Street 16 contact info |
UK (GLASGOW) | participant | 373˙417.00 |
5 |
DANMARKS TEKNISKE UNIVERSITET
Organization address
address: Anker Engelundsvej 1, Building 101A contact info |
DK (KONGENS LYNGBY) | participant | 360˙000.00 |
6 |
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse 101 contact info |
CH (ZUERICH) | participant | 317˙097.60 |
7 |
UNIVERSITEIT GENT
Organization address
address: SINT PIETERSNIEUWSTRAAT 25 contact info |
BE (GENT) | participant | 288˙000.00 |
8 |
BASF SE
Organization address
address: CARL BOSCH STRASSE 38 contact info |
DE (LUDWIGSHAFEN AM RHEIN) | participant | 270˙091.00 |
9 |
FIBRE PHOTONICS LTD
Organization address
address: Eliburn Office Park 3 contact info |
UK (Livingston) | participant | 244˙865.00 |
10 |
RHEINISCH-WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN
Organization address
address: Templergraben 55 contact info |
DE (AACHEN) | participant | 244˙000.00 |
11 |
ARKEMA FRANCE SA
Organization address
address: RUE ESTIENNE D ORVES 420 contact info |
FR (Colombes) | participant | 224˙980.00 |
12 |
CHROMACON AG
Organization address
address: TECHNOPARKSTRASSE 1 contact info |
CH (ZURICH) | participant | 180˙750.00 |
13 |
DSM CHEMICAL TECHNOLOGY R & D BV
Organization address
address: POSTSTRAAT 1 contact info |
NL (SITTARD) | participant | 137˙890.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'In response to world-wide changes in the chemical/biopharmaceutical industry, new market requirements for specific end-use product properties as well as to stricter energy, safety and environmental constraints a revolutionary approach is needed regarding equipment design, plant operation and new production paradigms that will result in better products and processes. Process intensification (PI) is the key technological pathway to drastically improve the sustainability of the chemical and biopharmaceutical processes by replacing the existing, inefficient plant equipment with new, intensified operations. PI comprises the development of novel equipment and production methods that can bring dramatic improvements in manufacturing and processing and lead to safer, cleaner, smaller and cheaper production routes. PI is expected to open up the way for the production of new products, unblock the potential for plant operation under less stable conditions and reform entire business models to foster just-in-time or distributed production. In a series of recent publications and roadmaps, PI has been identified as the ‘path for sustainable development’. The OPTICO project aims at overcoming the present limitations on implementing PI by establishing a new methodological design approach for sustainable, intensified chemical/biopharmaceutical plant design and operation through a flexible, integrated multi-scale modeling framework coupled with advanced process analytics tools and modern optimization/control techniques. It is envisaged that, within a 3 year time frame, the proposed work will enable the innovative process design and promote a substantial improvement in chemical/biopharmaceutical plant efficiency by reducing energy consumption, operating costs, handled volumes and generated wastes as well as by improving the process efficiency and safety.'
The European chemical and biochemical industry can benefit vastly from improvement of plant design and operation. An EU research project is developing an adaptive integrated computational framework to achieve maximum efficiency.